Find policies, billing codes, payers, states, and providers
HCPCS C1715: Brachytherapy Needle
HCPCS Level II code C1715 denotes a brachytherapy needle, a disposable medical device used to place radioactive sources for localized radiation treatment. Nationally, brachytherapy devices are a critical component of radiation oncology workflows for cancers where targeted radiotherapy reduces exposure to surrounding tissues. Accurate coding of device supplies affects billing transparency, device tracking, and aggregate utilization reporting across payers.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of what C1715 represents, common sites where the device is used, and which major payers are relevant for coverage considerations. The publication also outlines typical benchmarks and policy considerations related to device coding and billing practice for brachytherapy supplies where data is available.
This summary provides clinical context for revenue cycle and clinical teams, clarifies the primary service line for the device, and flags where input data is missing. Data not available in the input will be noted in the relevant sections of the full publication.
Customize your policy alerts
Sign up for hcpcs C1715 policy alerts
Get alerted when payer policies referencing C1715 are released or updated.
Monitor payer policy activity
Billing Code Overview
HCPCS Level II code C1715 represents a brachytherapy needle. This item is a medical device used in brachytherapy procedures to place radioactive sources directly into or near a tumor for localized radiation treatment.
Service Type: Brachytherapy device supply
Typical Site of Service: Hospital outpatient departments, ambulatory surgical centers, and radiation oncology clinics
Data not available in the input.